[Musculoskeletal pathology in children with infantile cerebral palsy: a new classification system].
Abstract
[BACKGROUND] Cerebral palsy (CP) is one of the most common causes of physical disability in childhood. While the Gross Motor Function Classification System (GMFCS) describes motor abilities, a unified classification for musculoskeletal pathologies was lacking. The newly proposed four-stage system-based on the Mercer Rang model-describes the progression of lower limb pathology and supports diagnosis, treatment planning, and research. STAGE 1: Hypertonia: From birth to about 6 years, spasticity and delayed motor development predominate; contractures are rare. Early intervention and spasticity management (e.g., botulinum toxin) are the focus. STAGE 2: Contractures: Between the ages of 4 and 12 years, discrepancies between muscle-tendon length and bone growth cause a reduced range of motion. Surgical muscle or tendon lengthening may be indicated. STAGE 3: Bony deformities: Bony deformities such as increased femoral anteversion or pes valgus occur simultaneously with soft tissue contractures; rotational osteotomies and combined multilevel surgeries (SEMLS) are often required. STAGE 4: Decompensated pathology: After puberty, irreversible deformities and joint degeneration develop. Surgery usually aims at pain reduction or stabilization (e.g., arthrodesis).
[CONCLUSION] This classification raises awareness of disease progression, helps select stage-appropriate treatments, and may prevent over- or undertreatment. Early recognition and intervention are crucial to avoid decompensation and improve long-term musculoskeletal and functional outcomes.
[CONCLUSION] This classification raises awareness of disease progression, helps select stage-appropriate treatments, and may prevent over- or undertreatment. Early recognition and intervention are crucial to avoid decompensation and improve long-term musculoskeletal and functional outcomes.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 1 | |
| 해부 | cerebral
|
scispacy | 1 | ||
| 해부 | lower limb
|
scispacy | 1 | ||
| 해부 | contractures
|
scispacy | 1 | ||
| 해부 | bone
|
scispacy | 1 | ||
| 해부 | muscle
|
scispacy | 1 | ||
| 해부 | tendon
|
scispacy | 1 | ||
| 해부 | femoral
|
scispacy | 1 | ||
| 해부 | soft tissue contractures
|
scispacy | 1 | ||
| 약물 | SEMLS
→ soft tissue contractures; rotational osteotomies and combined multilevel surgeries
|
scispacy | 1 | ||
| 약물 | [BACKGROUND] Cerebral palsy
|
scispacy | 1 | ||
| 질환 | infantile cerebral palsy
|
C0007789
Cerebral Palsy
|
scispacy | 1 | |
| 질환 | Cerebral palsy
|
C0007789
Cerebral Palsy
|
scispacy | 1 | |
| 질환 | physical disability
|
C0520817
Physical disability
|
scispacy | 1 | |
| 질환 | musculoskeletal pathologies
|
scispacy | 1 | ||
| 질환 | spasticity
|
C0026838
Muscle Spasticity
|
scispacy | 1 | |
| 질환 | deformities
|
C0000768
Congenital Abnormality
|
scispacy | 1 | |
| 질환 | pain
|
C0030193
Pain
|
scispacy | 1 | |
| 질환 | decompensation
|
C0231187
Decompensation
|
scispacy | 1 | |
| 질환 | long-term musculoskeletal and functional outcomes
|
scispacy | 1 | ||
| 질환 | muscle-tendon
|
scispacy | 1 | ||
| 질환 | disease
|
scispacy | 1 | ||
| 기타 | children
|
scispacy | 1 | ||
| 기타 | joint
|
scispacy | 1 |
📑 인용 관계
이 논문이 참조한 문헌 9
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.